[1]于清泳,赵 辉.结直肠癌肝转移患者TACE治疗后含表皮生长因子的纤维蛋白样细胞外基质2水平及意义 [J].介入放射学杂志,2021,30(10):1035-1040.
 YU Qingyong,ZHAO Hui..The level and significance of EGF containing fibulin-like extracellular matrix protein 2 in patients with liver metastases from colorectal cancer after TACE treatment[J].journal interventional radiology,2021,30(10):1035-1040.
点击复制

结直肠癌肝转移患者TACE治疗后含表皮生长因子的纤维蛋白样细胞外基质2水平及意义


()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年10
页码:
1035-1040
栏目:
临床研究
出版日期:
2021-10-25

文章信息/Info

Title:
The level and significance of EGF containing fibulin-like extracellular matrix protein 2 in patients with liver metastases from colorectal cancer after TACE treatment
作者:
于清泳 赵 辉
Author(s):
YU Qingyong ZHAO Hui.
Department of Intervention, Haian Municipal Hospital of Traditional Chinese Medicine, Nantong, Jiangsu Province 226699, China
关键词:
【关键词】 结直肠癌肝转移经导管动脉化疗栓塞术含表皮生长因子的纤维蛋白样细胞外基质2疗效
文献标志码:
A
摘要:
【摘要】 目的 分析结直肠癌肝转移患者外周血单个核细胞中含表皮生长因子的纤维蛋白样细胞外基质2(EGF containing fibulin-like extracellular matrix protein 2,EFEMP2)水平与TACE治疗疗效的关系。 方法 选择2015年3月至2017年7月在海安市中医院接受治疗的152例结直肠癌肝转移患者作为研究对象。用Ficoll密度梯度分离法分离外周血中单个核细胞;用蛋白质印迹法检测单个核细胞中EFEMP2表达水平。分析EFEMP2表达水平与TACE治疗疗效的关系。结果 生存组和死亡组EFEMP2水平均随时间进展呈升高趋势。生存组不同时间节点时EFEMP2水平均高于死亡组,差异均有统计学意义(P<0.05)。高EFEMP2组中位生存时间高于低EFEMP2组,差异有统计学意义(P<0.05)。Cox回归分析结果显示靶向治疗和T3-EFEMP2均是结直肠癌肝转移患者3年生存预后的独立保护因素(P<0.05)。限制性立方样条拟合Cox回归分析结果显示T3-EFEMP2与结直肠癌肝转移患者3年生存预后呈非线性关系(P<0.05)。结论 直肠癌肝转移患者外周血单个核细胞中EFEMP2水平与TACE治疗疗效有关,其水平低提示TACE治疗临床获益较小。

参考文献/References:

[1] 郭 锐,林征宇,陈 锦,等. 1.5T MRI引导下经皮射频消融治疗结直肠癌肝转移疗效分析[J]. 介入放射学杂志, 2019, 28:1100- 1104.
[2] 张成佳,邵泽锋,何仕诚,等. 卡培他滨结合介入疗法在结直肠癌术后肝转移患者的疗效与安全性[J]. 肝脏, 2018, 23:1105- 1108.
[3] 李 慧,江 旭,杨朝爱,等. 动脉微泵灌注奥沙利铂治疗结直肠癌术后肝转移[J]. 中国介入影像与治疗学, 2017, 14:455- 459.
[4] 徐 毅,唐 岩,丁 波,等. TACE联合射频消融治疗结直肠癌肝转移的疗效及生存分析[J]. 国际肿瘤学杂志, 2019, 46:673- 677.
[5] Chen J, Zhang J, Liu X, et al. Overexpression of fibulin- 4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma[J]. Oncol Rep, 2014, 31: 2601- 2610.
[6] Wlazlinski A, Engers R, Hoffmann MJ, et al. Downregulation of several fibulin genes in prostate cancer[J]. Prostate, 2007, 67: 1770- 1780.
[7] Zhao J, Xu J, Zhao J, et al. EFEMP2 promotes colon cancer cell invasion and growth through the ERK1/2 signaling pathway[J]. Int J Clin Exp Pathol, 2019, 12:851- 856.
[8] Kang N, Zhou J, Xu J, et al. EFEMP2 inhibits breast cancer invasion and metastasis in vitro and in vivo[J]. Onco Targets Ther, 2019, 12: 8915- 8933.
[9] Zhou Q, Chen S, Lu M, et al. EFEMP2 suppresses epithelial- mesenchymal transition via Wnt/β- catenin signaling pathway in human bladder cancer[J]. Int J Biol Sci, 2019, 15: 2139- 2155.
[10] Song L, Li XX, Liu XY, et al. EFEMP2 suppresses the invasion of lung cancer cells by inhibiting epithelial- mesenchymal transition (EMT) and down- regulating MMPs[J]. Onco Targets Ther, 2020, 13: 1375- 1396.
[11] 中国医师协会介入医师分会.中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J]. 中华医学杂志, 2018, 98:3811- 3819.
[12] Tang X, Wang J, Xia X, et al. Elevated expression of ciRS- 7 in peripheral blood mononuclear cells from rheumatoid arthritis patients[J]. Diagn Pathol, 2019, 14: 11.
[13] Huang L, Wang Z, Chang Y, et al. EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma[J]. Aging(Albany NY), 2020, 12: 8397- 8412.
[14] Zhong W, Hou H, Liu T, et al. Cartilage oligomeric matrix protein promotes epithelial- mesenchymal transition by interacting with transgelin in colorectal cancer[J]. Theranostics, 2020, 10: 8790- 8806.
[15] Kim SJ, Kim YS, Kim JH, et al. Activation of ERK1/2- mTORC1- NOX4 mediates TGF- β1- induced epithelial- mesenchymal transition and fibrosis in retinal pigment epithelial cells[J]. Biochem Biophys Res Commun, 2020, 529: 747- 752.
[16] 陈 勇. EFEMP2在结肠癌组织中的表达及其临床意义[D].陕西:西安医学院, 2019.
[17] 叶 涛,王耀辉,夏景林,等. 肝动脉化疗栓塞治疗结直肠癌肝转移的疗效和预后影响因素[J]. 中华肿瘤杂志, 2012, 34:706- 709.
[18] 鲁全芝. 结直肠癌肝转移患者预后的影响因素研究[J]. 中国实用医刊, 2018, 45:32- 35.
[19] Obaya AJ, Rua S, Moncada- Pazos A, et al. The dual role of fibulins in tumorigenesis[J]. Cancer Lett, 2012, 325: 132- 138.

相似文献/References:

[1]李晓光,金征宇,杨宁,等.经动脉灌注化疗或栓塞治疗恶性胰岛素瘤肝转移[J].介入放射学杂志,2008,(11):803.
 LI Xiaoguang,JIN Zhengyu,YANG Ning,et al.Transcatheter arterial chemoperfusion or chemoembolizaiton for treatment of liver metastasis from malignant insulinoma[J].journal interventional radiology,2008,(10):803.
[2]李晓光,金征宇,潘杰,等.肝动脉化疗或栓塞治疗胰腺神经内分泌肿瘤肝转移的疗效分析[J].介入放射学杂志,2010,(06):442.
 LI Xiaoguang,JIN Zhengyu,PAN Jie,et al.Hepatic transarterial chemoperfusion and chemoembolization for the treatment of liver metastases from pancreatic neuroendocrine tumors:a therapeutic analysis[J].journal interventional radiology,2010,(10):442.
[3]彭晶晶,谭 勇,谭 艳,等. 125I粒子植入治疗结肠直肠癌肝转移[J].介入放射学杂志,2012,(09):773.
 PENG Jing- jing,TAN Yong,TAN- Yan,et al. Interstitial implantation of 125I seeds for the treatment of colorectal liver metastases[J].journal interventional radiology,2012,(10):773.
[4]王惠文,刘瑞宝,李晓婧,等.载药微球-TACE治疗难治性妇科恶性肿瘤肝转移12例[J].介入放射学杂志,2021,30(06):568.
 WANG Huiwen,LIU Ruibao,LI Xiaojing,et al.Drug- eluting beads - TACE for the treatment of refractory liver metastases from synecological malignant tumors: preliminary results in 12 patients[J].journal interventional radiology,2021,30(10):568.
[5]张雪婷,周祖邦,时润莉,等.微波消融与手术治疗结直肠癌肝转移临床疗效的meta分析 [J].介入放射学杂志,2022,31(01):49.
 ZHANG Xueting,ZHOU Zubang,SHI Runli,et al.Microwave ablation versus surgical resection for the treatment of colorectal liver metastases: a meta-analysis[J].journal interventional radiology,2022,31(10):49.

备注/Memo

备注/Memo:
(收稿日期:2020- 09- 23)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2021-10-15